blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2836229

EP2836229 - LIPOSOMES CONTAINING OLIGOPEPTIDE FRAGMENTS OF MYELIN BASIC PROTEIN, A PHARMACEUTICAL COMPOSITION AND A METHOD FOR TREATMENT OF MULTIPLE SCLEROSIS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.10.2019
Database last updated on 19.07.2024
FormerThe patent has been granted
Status updated on  02.11.2018
FormerGrant of patent is intended
Status updated on  27.10.2018
FormerExamination is in progress
Status updated on  06.10.2018
FormerGrant of patent is intended
Status updated on  03.06.2018
FormerExamination is in progress
Status updated on  04.11.2016
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK
published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Lipoxen Technologies Limited
Fifth Floor
15 Whitehall
London
SW1 2DD / GB
[2018/49]
Former [2015/08]For all designated states
Lipoxen Technologies Limited
Fifth Floor
15 Whitehall
London
SW1 2DD / GB
Inventor(s)01 / GABIVOV, Alexander
Yauzsky blv 14-10
Moscow 8, 10902 / RU
02 / BELOGUROV, Alexey
ul. Osenniya 4/1-238
Moscow 9, 12160 / RU
03 / PONOMARENKO, Natalia
ul. Gubkina 4-92
Moscow 3, 11933 / RU
04 / SMIRNOV, Ivan
ul. Pionerstroya 29-33
St. Petersburg 6, 19720 / RU
05 / BACON, Andrew
Lipoxen Technologies Ltd.
99 Hayden Avenue Suite 230
Lexington, MA 02421 / US
06 / GREGORIADIS, Gregory
Lipoxen Technologies Ltd.
99 Hayden Avenue Suite 230
Lexington, MA 02421 / US
 [2018/49]
Former [2015/08]01 / GABIVOV, Alexander
Yauzsky blv 14-10
Moscow 810902 / RU
02 / BELOGUROV, Alexey
ul. Osenniya 4/1-238
Moscow 912160 / RU
03 / PONOMARENKO, Natalia
ul. Gubkina 4-92
Moscow 311933 / RU
04 / SMIRNOV, Ivan
ul. Pionerstroya 29-33
St. Petersburg 619720 / RU
05 / BACON, Andrew
Lipoxen Technologies Ltd.
99 Hayden Avenue Suite 230
Lexington, MA 02421 / US
06 / GREGORIADIS, Gregory
Lipoxen Technologies Ltd.
99 Hayden Avenue Suite 230
Lexington, MA 02421 / US
Representative(s)Icosa
83 avenue Denfert-Rochereau
75014 Paris / FR
[2018/49]
Former [2015/08]Schlich, George, et al
Schlich
9 St Catherine's Road
Littlehampton, West Sussex BN17 5HS / GB
Application number, filing date13715237.711.04.2013
[2018/49]
WO2013EP57629
Priority number, dateUS20121344478811.04.2012         Original published format: US201213444788
[2015/08]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013153179
Date:17.10.2013
Language:EN
[2013/42]
Type: A1 Application with search report 
No.:EP2836229
Date:18.02.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 17.10.2013 takes the place of the publication of the European patent application.
[2015/08]
Type: B1 Patent specification 
No.:EP2836229
Date:05.12.2018
Language:EN
[2018/49]
Search report(s)International search report - published on:EP17.10.2013
ClassificationIPC:A61K39/00, A61K9/127, C07K14/47
[2015/08]
CPC:
A61K9/1271 (EP); A61K39/0008 (EP,KR,RU); A61K9/127 (KR,RU);
B82Y5/00 (KR); C07K14/4713 (EP,KR,RU); A61K2039/55555 (EP);
A61K2039/55566 (EP); A61K2039/55594 (EP); A61K2039/70 (EP);
A61K2121/00 (KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/08]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:LIPOSOME MIT OLIGOPEPTIDFRAGMENTEN EINES BASISCHEN MYELINPROTEINS, PHARMAZEUTISCHE ZUSAMMENSETZUNG UND VERFAHREN ZUR BEHANDLUNG VON MULTIPLER SKLEROSE[2015/08]
English:LIPOSOMES CONTAINING OLIGOPEPTIDE FRAGMENTS OF MYELIN BASIC PROTEIN, A PHARMACEUTICAL COMPOSITION AND A METHOD FOR TREATMENT OF MULTIPLE SCLEROSIS[2015/08]
French:LIPOSOMES CONTENANT DES FRAGMENTS OLIGOPEPTIDIQUES DE LA PROTÉINE BASIQUE DE LA MYÉLINE, COMPOSITION PHARMACEUTIQUE ET PROCÉDÉ DE TRAITEMENT DE LA SCLÉROSE EN PLAQUES[2015/08]
Entry into regional phase07.10.2014National basic fee paid 
07.10.2014Designation fee(s) paid 
07.10.2014Examination fee paid 
Examination procedure07.10.2014Examination requested  [2015/08]
15.05.2015Amendment by applicant (claims and/or description)
23.06.2016Despatch of a communication from the examining division (Time limit: M04)
02.11.2016Reply to a communication from the examining division
21.06.2017Despatch of a communication from the examining division (Time limit: M06)
21.12.2017Reply to a communication from the examining division
19.02.2018Despatch of a communication from the examining division (Time limit: M02)
20.04.2018Reply to a communication from the examining division
04.06.2018Communication of intention to grant the patent
04.10.2018Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
04.10.2018Fee for grant paid
04.10.2018Fee for publishing/printing paid
26.10.2018Information about intention to grant a patent
26.10.2018Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  23.06.2016
Opposition(s)06.09.2019No opposition filed within time limit [2019/46]
Fees paidRenewal fee
17.07.2015Renewal fee patent year 03
25.04.2016Renewal fee patent year 04
25.04.2017Renewal fee patent year 05
25.04.2018Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
30.04.201503   M06   Fee paid on   17.07.2015
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU11.04.2013
AL05.12.2018
AT05.12.2018
CY05.12.2018
CZ05.12.2018
DK05.12.2018
EE05.12.2018
FI05.12.2018
HR05.12.2018
LT05.12.2018
LV05.12.2018
MC05.12.2018
MK05.12.2018
MT05.12.2018
NL05.12.2018
PL05.12.2018
RO05.12.2018
RS05.12.2018
SE05.12.2018
SI05.12.2018
SK05.12.2018
SM05.12.2018
TR05.12.2018
BG05.03.2019
NO05.03.2019
GR06.03.2019
IS05.04.2019
PT05.04.2019
LU11.04.2019
BE30.04.2019
CH30.04.2019
LI30.04.2019
[2022/31]
Former [2021/34]HU11.04.2013
AL05.12.2018
AT05.12.2018
CY05.12.2018
CZ05.12.2018
DK05.12.2018
EE05.12.2018
FI05.12.2018
HR05.12.2018
LT05.12.2018
LV05.12.2018
MC05.12.2018
MT05.12.2018
NL05.12.2018
PL05.12.2018
RO05.12.2018
RS05.12.2018
SE05.12.2018
SI05.12.2018
SK05.12.2018
SM05.12.2018
TR05.12.2018
BG05.03.2019
NO05.03.2019
GR06.03.2019
IS05.04.2019
PT05.04.2019
LU11.04.2019
BE30.04.2019
CH30.04.2019
LI30.04.2019
Former [2021/33]HU11.04.2013
AL05.12.2018
AT05.12.2018
CY05.12.2018
CZ05.12.2018
DK05.12.2018
EE05.12.2018
FI05.12.2018
HR05.12.2018
LT05.12.2018
LV05.12.2018
MC05.12.2018
NL05.12.2018
PL05.12.2018
RO05.12.2018
RS05.12.2018
SE05.12.2018
SI05.12.2018
SK05.12.2018
SM05.12.2018
TR05.12.2018
BG05.03.2019
NO05.03.2019
GR06.03.2019
IS05.04.2019
PT05.04.2019
LU11.04.2019
BE30.04.2019
CH30.04.2019
LI30.04.2019
Former [2021/26]AL05.12.2018
AT05.12.2018
CY05.12.2018
CZ05.12.2018
DK05.12.2018
EE05.12.2018
FI05.12.2018
HR05.12.2018
LT05.12.2018
LV05.12.2018
MC05.12.2018
NL05.12.2018
PL05.12.2018
RO05.12.2018
RS05.12.2018
SE05.12.2018
SI05.12.2018
SK05.12.2018
SM05.12.2018
TR05.12.2018
BG05.03.2019
NO05.03.2019
GR06.03.2019
IS05.04.2019
PT05.04.2019
LU11.04.2019
BE30.04.2019
CH30.04.2019
LI30.04.2019
Former [2020/17]AL05.12.2018
AT05.12.2018
CZ05.12.2018
DK05.12.2018
EE05.12.2018
FI05.12.2018
HR05.12.2018
LT05.12.2018
LV05.12.2018
MC05.12.2018
NL05.12.2018
PL05.12.2018
RO05.12.2018
RS05.12.2018
SE05.12.2018
SI05.12.2018
SK05.12.2018
SM05.12.2018
TR05.12.2018
BG05.03.2019
NO05.03.2019
GR06.03.2019
IS05.04.2019
PT05.04.2019
LU11.04.2019
BE30.04.2019
CH30.04.2019
LI30.04.2019
Former [2020/11]AL05.12.2018
AT05.12.2018
CZ05.12.2018
DK05.12.2018
EE05.12.2018
FI05.12.2018
HR05.12.2018
LT05.12.2018
LV05.12.2018
MC05.12.2018
NL05.12.2018
PL05.12.2018
RO05.12.2018
RS05.12.2018
SE05.12.2018
SI05.12.2018
SK05.12.2018
SM05.12.2018
BG05.03.2019
NO05.03.2019
GR06.03.2019
IS05.04.2019
PT05.04.2019
LU11.04.2019
BE30.04.2019
CH30.04.2019
LI30.04.2019
Former [2020/04]AL05.12.2018
AT05.12.2018
CZ05.12.2018
DK05.12.2018
EE05.12.2018
FI05.12.2018
HR05.12.2018
LT05.12.2018
LV05.12.2018
MC05.12.2018
NL05.12.2018
PL05.12.2018
RO05.12.2018
RS05.12.2018
SE05.12.2018
SI05.12.2018
SK05.12.2018
SM05.12.2018
BG05.03.2019
NO05.03.2019
GR06.03.2019
IS05.04.2019
PT05.04.2019
LU11.04.2019
Former [2020/02]AL05.12.2018
AT05.12.2018
CZ05.12.2018
DK05.12.2018
EE05.12.2018
FI05.12.2018
HR05.12.2018
LT05.12.2018
LV05.12.2018
MC05.12.2018
NL05.12.2018
PL05.12.2018
RO05.12.2018
RS05.12.2018
SE05.12.2018
SI05.12.2018
SK05.12.2018
SM05.12.2018
BG05.03.2019
NO05.03.2019
GR06.03.2019
IS05.04.2019
PT05.04.2019
Former [2019/50]AL05.12.2018
AT05.12.2018
CZ05.12.2018
DK05.12.2018
EE05.12.2018
FI05.12.2018
HR05.12.2018
LT05.12.2018
LV05.12.2018
NL05.12.2018
PL05.12.2018
RO05.12.2018
RS05.12.2018
SE05.12.2018
SI05.12.2018
SK05.12.2018
SM05.12.2018
BG05.03.2019
NO05.03.2019
GR06.03.2019
IS05.04.2019
PT05.04.2019
Former [2019/48]AL05.12.2018
AT05.12.2018
CZ05.12.2018
DK05.12.2018
EE05.12.2018
FI05.12.2018
HR05.12.2018
LT05.12.2018
LV05.12.2018
NL05.12.2018
PL05.12.2018
RO05.12.2018
RS05.12.2018
SE05.12.2018
SK05.12.2018
SM05.12.2018
BG05.03.2019
NO05.03.2019
GR06.03.2019
IS05.04.2019
PT05.04.2019
Former [2019/39]AL05.12.2018
AT05.12.2018
CZ05.12.2018
EE05.12.2018
FI05.12.2018
HR05.12.2018
LT05.12.2018
LV05.12.2018
NL05.12.2018
PL05.12.2018
RO05.12.2018
RS05.12.2018
SE05.12.2018
SK05.12.2018
SM05.12.2018
BG05.03.2019
NO05.03.2019
GR06.03.2019
IS05.04.2019
PT05.04.2019
Former [2019/37]AL05.12.2018
AT05.12.2018
CZ05.12.2018
EE05.12.2018
FI05.12.2018
HR05.12.2018
LT05.12.2018
LV05.12.2018
NL05.12.2018
PL05.12.2018
RO05.12.2018
RS05.12.2018
SE05.12.2018
SM05.12.2018
BG05.03.2019
NO05.03.2019
GR06.03.2019
PT05.04.2019
Former [2019/35]AL05.12.2018
AT05.12.2018
CZ05.12.2018
FI05.12.2018
HR05.12.2018
LT05.12.2018
LV05.12.2018
NL05.12.2018
PL05.12.2018
RS05.12.2018
SE05.12.2018
BG05.03.2019
NO05.03.2019
GR06.03.2019
PT05.04.2019
Former [2019/33]AL05.12.2018
AT05.12.2018
FI05.12.2018
HR05.12.2018
LT05.12.2018
LV05.12.2018
NL05.12.2018
RS05.12.2018
SE05.12.2018
BG05.03.2019
NO05.03.2019
GR06.03.2019
PT05.04.2019
Former [2019/30]AL05.12.2018
AT05.12.2018
FI05.12.2018
HR05.12.2018
LT05.12.2018
LV05.12.2018
NL05.12.2018
RS05.12.2018
SE05.12.2018
BG05.03.2019
NO05.03.2019
GR06.03.2019
Former [2019/26]AL05.12.2018
AT05.12.2018
FI05.12.2018
HR05.12.2018
LT05.12.2018
LV05.12.2018
RS05.12.2018
SE05.12.2018
BG05.03.2019
NO05.03.2019
GR06.03.2019
Former [2019/25]AT05.12.2018
FI05.12.2018
HR05.12.2018
LT05.12.2018
LV05.12.2018
RS05.12.2018
SE05.12.2018
BG05.03.2019
NO05.03.2019
GR06.03.2019
Former [2019/24]AT05.12.2018
FI05.12.2018
HR05.12.2018
LT05.12.2018
LV05.12.2018
SE05.12.2018
BG05.03.2019
NO05.03.2019
GR06.03.2019
Former [2019/23]AT05.12.2018
FI05.12.2018
HR05.12.2018
LT05.12.2018
LV05.12.2018
BG05.03.2019
NO05.03.2019
Former [2019/22]FI05.12.2018
LT05.12.2018
BG05.03.2019
NO05.03.2019
Former [2019/21]FI05.12.2018
LT05.12.2018
NO05.03.2019
Former [2019/20]LT05.12.2018
NO05.03.2019
Cited inInternational search[XI]WO2010024927  (UNIV NEW YORK STATE RES FOUND [US], et al);
 [XI]WO2011065867  (MINISTRY OF INDUSTRY AND TRADE OF THE RUSSIAN FEDERATION [RU], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.